Association of lipid profile alterations with severe forms of dengue in humans

Archives of Virology

Volumn 160, Issue 7, 2015, Pages 1687-1692

  Durán, Anyelo ^a,b   Carrero, Rafaela ^a   Parra, Belkis ^a   González, Andrea ^a   Delgado, Lineth ^a   Mosquera, Jesús ^a   Valero, Nereida ^a,b  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Sociedad Venezolana de Microbiología   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VIRUS;

LIPIDS;

ADOLESCENT; ADULT; AGED; BLOOD; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; CYTOLOGY; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PLATELET COUNT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; PLATELET COUNT; YOUNG ADULT;

EID: 84930869323     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2433-z     Document Type: Article

References (38)

1. Normile D (2013) Surprising new dengue virus throws a spanner in disease control efforts. Science 342:415
2. (2009) Dengue guidelines for diagnosis, treatment, prevention and control, 3rd edn. World Health Organization, Geneva. http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf
3. Voisset C, Callens N, Blanchard E et al (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280:7793–7799
4. Andreo U, Maillard P, Kalinina O et al (2007) Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol 9:2445–2456
5. Agnello V, Abel G, Elfahal M et al (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96:12766–12771
6. Andre P, Komurian-Pradel F, Deforges S et al (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928
7. Voisset C, Op de Beeck A, Horellou P et al (2006) High density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87:2577–2581
8. Van Gorp ECM, Suharti C, Mairuhu ATA et al (2002) Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis 34:1150–1153
9. Suvarna JC, Rane PP (2009) Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop Med Int Health 14:576–585. doi:10.1111/j.1365-3156.2009.02261.x
10. Villar-Centeno LA, Díaz-Quijano FA, Martínez-Vega RA et al (2008) Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg 78:370–374
11. Heaton NS, Randall G (2011) Microbes and metabolism: multifaceted roles for lipids in viral infection. Trends Microbiol 19:368–375. doi:10.1016/j.tim.2011.03.007
12. Tsai JJ, Chokephaibulkit K, Chen PC et al (2013) Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. J Biomed Sci 20:88. http://www.jbiomedsci.com/content/20/1/88
13. Huy NT, Van Giang T, Thuy DHD et al (2013) Factors associated with dengue shock syndrome: a systematic review and meta- analysis. PLoS Negl Trop Dis 7:e2412. doi:10.1371/journal.pntd.0002412
14. Friedewald W, Levy R, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
15. The National Cholesterol Education Program. NCEP 2001. https://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf
16. Stephenson JR (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 83:308–314
17. Mongkolsapaya J, Dejnirattisai W, Xu XN et al (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927
18. Dejnirattisai W, Jumnainsong A, Onsirisakul N et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748
19. Stephens HA (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338:99–114
20. Lye DC, Lee VJ, Sun Y et al (2010) The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis 14:e410–e413
21. Li Y, Kakinami C, Li Q et al (2013) Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI. PLoS ONE 8:e70390. doi:10.1371/journal.pone.0070390
22. Guevara J, Prashad N, Ermolinksy B et al (2010) Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res 51:1704–1718
23. Soto-Acosta R, Mosso C, Cervantes-Salazar M et al (2013) The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology 442:132–147
24. Lee CJ, Lin HR, Liao CL (2008) Cholesterol effectively blocks entry of flavivirus. J Virol 82:6470–6480. doi:10.1128/JVI.00117-08
25. Carro AC, Damonte EB (2013) Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res 174:78–87
26. Garcıa-Cordero J, Juarez L, Gonzalez- Merchand JA et al (2014) Caveolin-1 in lipid rafts interacts with dengue virus NS3 during polyprotein processing and replication in HMEC-1 cells. PLoS ONE 9:e90704. doi:10.1371/journal.pone.0090704
27. Rothwell C, LeBreton A, Ng CY et al (2009) Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389:8–19
28. Faustino AF, Carvalho FA, Ivo C et al (2014) Dengue virus capsid protein interacts specifically with very low-density lipoproteins. Nanomedicine 10:247–255. doi:10.1016/j.nano.2013.06.004
29. Gutschea I, Coulibalya F, Vossb JE et al (2011) Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. PNAS 108:8003–8008. doi:10.1073/pnas.1017338108
30. Nowack R, Wiedemann G (2010) Pancytopenia with severe thrombocytopenia in a patient treated with twice-weekly LDL-apheresis by polyacrylate adsorption from whole blood. J Clin Apheresis 25:77–80
31. Shahbazian H, Mohtashami AZ, Ghorbani A et al (2011) Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. Nefrologia 31:58–65. doi:10.3265/Nefrologia.pre2010
32. Dole VD, Matuskova J, Vasile E et al (2008) Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor–deficient mice. Arterioscler Thromb Vasc Biol 28:1111–1116
33. Lin Z-W, Ho H-C, Yang C-H et al (2009) Rosuvastatin-induced thrombocytopenic purpura. Dermatol Sin 27:235–240
34. Leaf DA (2008) Hypertriglyceridemia: a guide to assessment and treatment. Hosp Phys 32:17–23
35. Faivre L, Saugier-Veber P, Pais de Barros JP et al (2005) Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation. Eur J Hum Genet 13:1186–1191
36. Valero N, Mosquera J, Levy A et al (2014) Differential induction of cytokines by human neonatal, adult, and elderly monocyte/macrophages infected with dengue virus. Viral Immunol 27:151–159. doi:10.1089/vim.2013.0123
37. Ly H, Francone OL, Fielding CJ et al (1995) Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res 36:1254–1263
38. Ettinger WH, Varma VK, Sorci-Thomas M et al (1994) Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler Thromb 14:8–13